Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Polypoidal Choroidal Vasculopathy”

61 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 61 results

Early research (Phase 1)Ended earlyNCT01334255
What this trial is testing

ISONEP to Treat Persistent Pigment Epithelial Detachment (PED) in Subjects With Exudative Age-Related Macular Degeneration (AMD) or Polypoidal Choroidal Vasculopathy (PCV)

Who this might be right for
Pigment Epithelial Detachment
Lpath, Inc. 12
Not applicableUnknownNCT00383812
What this trial is testing

Intravitreal Bevacizumab for Polypoidal Choroidal Vasculopathy

Who this might be right for
Polypoidal Choroidal Vasculopathy
Asan Medical Center 20
Large-scale testing (Phase 3)Looking for participantsNCT07389980
What this trial is testing

Prospective Trial of the Efficacy and Safety of a Personalized Regimen of High-dose Aflibercept 8mg on Treatment-naive Polypoidal Choroidal Vasculopathy: the PALLAS Trial

Who this might be right for
Polypoidal Choroidal VasculopathyPolypoidal Choroidal Vasculopathy (PCV)
Yeungnam University College of Medicine 50
Post-approval studies (Phase 4)UnknownNCT04380974
What this trial is testing

Efficacy and Safety of Two Regimens of Anti-VEGF Therapy in Chinese Patients With Polypoidal Choroidal Vasculopathy

Who this might be right for
Polypoidal Choroidal Vasculopathy
Xiaodong Sun 102
Post-approval studies (Phase 4)Study completedNCT01871376
What this trial is testing

Intravitreal Aflibercept Injection for Polypoidal Choroidal Vasculopathy With Hemorrhage or Exudation

Who this might be right for
Polypoidal Choroidal Vasculopathy
Gregg T. Kokame, MD 25
Large-scale testing (Phase 3)Looking for participantsNCT07461441
What this trial is testing

Efficacy and Durability of a Personalized Treat-and-extend Regimen of Faricimab for Treatment-naive Polypoidal Choroidal Vasculopathy

Who this might be right for
Polypoidal Choroidal Vasculopathy (PCV)Age Related Macular Degeneration
Yeungnam University College of Medicine 50
Not applicableStudy completedNCT03459144
What this trial is testing

Comparison of PDT, Intravitreal Ranibizumab and Combination for Polypoidal Choroidal Vasculopathy Under 1+PRN Regimen

Who this might be right for
Polypoidal Choroidal Vasculopathy
Sun Yat-sen University 60
Not applicableUnknownNCT04707027
What this trial is testing

Interval of Disease Inactivity After Complete Polypoidal Regression in PCV Receiving Aflibercept

Who this might be right for
Polypoidal Choroidal Vasculopathy
Chiang Mai University 80
Not applicableUnknownNCT02597855
What this trial is testing

Short-term Efficacy of Intravitreal Afilibercept Depending on Subtypes of Polypoidal Choroidal Vasculopathy: Polypoidal Choroidal Neovascularization or Idiopathic Choroidal Vasculopathy

Who this might be right for
Polypoidal Choroidal Vasculopathy
Yeungnam University College of Medicine 29
Large-scale testing (Phase 3)Study completedNCT05666804
What this trial is testing

Study Assessing the Efficacy and Safety of a Personalized Monotherapy Regimen of Brolucizumab in Patients With Symptomatic Macular Polypoidal Choroidal Vasculopathy

Who this might be right for
Macular Polypoidal Choroidal Vasculopathy (PCV)
Novartis Pharmaceuticals 148
Post-approval studies (Phase 4)UnknownNCT02806752
What this trial is testing

Intravitreal Ranibizumab and TA Combination Therapy vs. Ranibizumab Monotherapy in Polypoidal Choroidal Vasculopathy

Who this might be right for
Wet Macular Degeneration
Aier School of Ophthalmology, Central South University 120
Post-approval studies (Phase 4)UnknownNCT02681783
What this trial is testing

PRedictive Factors and Changes From Treatment in iPCV Versus CSR Versus nAMD With afLibercept

Who this might be right for
Central Serous ChorioretinopathyAge Related Macular DegenerationIdiopathic Poplypoidal Choroidal Vasculopathy
Sunnybrook Health Sciences Centre 90
Not applicableUnknownNCT05639660
What this trial is testing

Clinical Implication of Aflibercept in PCV Treatment in China

Who this might be right for
Polypoidal Choroidal Vasculopathy
Peking Union Medical College Hospital 1,000
Post-approval studies (Phase 4)UnknownNCT02092532
What this trial is testing

Intravitreal Aflibercept for Neovascular Polypoidal Choroidal Vasculopathy (RIVAL Trial)

Who this might be right for
Neovascular Polypoidal Choroidal Vasculopathy
Southeast Retina Center, Georgia 20
Post-approval studies (Phase 4)Study completedNCT02120950
What this trial is testing

Aflibercept in Polypoidal Choroidal Vasculopathy

Who this might be right for
Neovascular Macular Degeneration
Bayer 333
Testing effectiveness (Phase 2)WithdrawnNCT03374670
What this trial is testing

ZIMURA in Combination With Eylea in Patients With Idiopathic Polypoidal Choroidal Vasculopathy (IPCV)

Who this might be right for
Idiopathic Polypoidal Choroidal Vasculopathy
Ophthotech Corporation
Post-approval studies (Phase 4)Study completedNCT02495181
What this trial is testing

Randomized, Double-masked, Sham-controlled Phase 4 Study, Efficacy, Safety, and Tolerability of Intravitreal Aflibercept Monotherapy Compared to Aflibercept With Adjunctive Photodynamic Therapy in Patients With Polypoidal Choroidal Vasculopathy

Who this might be right for
Polypoidal Choroidal Vasculopathy
Association for Innovation and Biomedical Research on Light and Image 50
Not applicableStudy completedNCT05229237
What this trial is testing

Conbercept for Polypoidal Choroidal Vasculopathy（START Study）

Who this might be right for
Polypoidal Choroidal VasculopathyConbercept
Peking Union Medical College Hospital 500
Not applicableStudy completedNCT03941587
What this trial is testing

Comparing Intravitreal Aflibercept Monotherapy vs Aflibercept Combined With Reduced Fluence PDT in PCV Treatment

Who this might be right for
Polypoidal Choroidal Vasculopathy
Singapore National Eye Centre 60
Post-approval studies (Phase 4)Study completedNCT00331435
What this trial is testing

PDT Study for Exudative AMD With PCV

Who this might be right for
Age Related Macular Degeneration
Ophthalmic PDT Study Group 113
Load More Results